Literature DB >> 17700045

The road to recovery from depression--don't drive today with yesterday's map.

Giovanni A Fava1, Elena Tomba, Silvana Grandi.   

Abstract

The issue of recovery is getting increasing attention in depression research, particularly after the publication of the STAR*D results. The paper analyzes some issues which may hinder effective treatment of major depressive disorders: the inadequacies of a cross-sectional DSM assessment without clinical differentiation of the extent, development and seriousness of the disturbances (staging); over-emphasis on and prolongation of drug treatment, without paying attention to problems related to tolerance; neglect of the active role of the patient in achieving recovery, with the integration of psychotherapeutic strategies in a sequential model. If we are able to remove the conceptual obstacles which obstruct our view of depression and silence the sound of propaganda, we may then become aware of a different scenario in mood disorders and be able to develop therapeutic strategies of enduring quality. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17700045     DOI: 10.1159/000104701

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  18 in total

Review 1.  Psychosomatic medicine is a comprehensive field, not a synonym for consultation liaison psychiatry.

Authors:  Giovanni Andrea Fava; Carlotta Belaise; Nicoletta Sonino
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

2.  The mental health clinic: a new model.

Authors:  Giovanni A Fava; Seugn K Park; Steven L Dubovsky
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

Review 3.  New modalities of assessment and treatment planning in depression: the sequential approach.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

4.  Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot study.

Authors:  Michael A Rapp; Nina Rieckmann; David A Lessman; Cheuk Y Tang; Robert Paulino; Matthew M Burg; Karina W Davidson
Journal:  Psychother Psychosom       Date:  2010-02-20       Impact factor: 17.659

5.  Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study.

Authors:  Carlos M Grilo; Robert L Stout; John C Markowitz; Charles A Sanislow; Emily B Ansell; Andrew E Skodol; Donna S Bender; Anthony Pinto; M Tracie Shea; Shirley Yen; John G Gunderson; Leslie C Morey; Christopher J Hopwood; Thomas H McGlashan
Journal:  J Clin Psychiatry       Date:  2010-06-15       Impact factor: 4.384

6.  Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V.

Authors:  Andrew A Nierenberg; Mark Hyman Rapaport; Pamela J Schettler; Robert H Howland; Juliana A Smith; Deidre Edwards; Trisha Schneider; David Mischoulon
Journal:  CNS Neurosci Ther       Date:  2010-03-04       Impact factor: 5.243

Review 7.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 8.  Factors associated with dropout from treatment for eating disorders: a comprehensive literature review.

Authors:  Secondo Fassino; Andrea Pierò; Elena Tomba; Giovanni Abbate-Daga
Journal:  BMC Psychiatry       Date:  2009-10-09       Impact factor: 3.630

9.  Pain as a predictor of depression treatment outcomes in women with childhood sexual abuse.

Authors:  Ellen L Poleshuck; Nancy L Talbot; Haiyan Su; Xin Tu; Linda Chaudron; Stephanie Gamble; Donna E Giles
Journal:  Compr Psychiatry       Date:  2008-10-15       Impact factor: 3.735

Review 10.  Redefining affective disorders: relevance for drug development.

Authors:  Steven D Targum; Mark H Pollack; Maurizio Fava
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.